FEMY Latest Press Releases

-- August 26, 2026 --

Femasys Partners with UNC Health to Introduce Its FemaSeed Fertility Portfolio Across Statewide OB/GYN Care Locations Globe Newswire 9:00 AM

-- August 19, 2026 --

Femasys Announces FDA Approval of Modular PMA Submission Approach for FemBloc Globe Newswire 9:00 AM

-- August 14, 2026 --

Femasys Announces Financial Results for Quarter Ended June 30, 2026 and Provides Corporate Update Globe Newswire 4:05 PM

-- August 12, 2026 --

Femasys Strengthens and Extends Global Patent Protection for FemBloc with First Issued Blended Polymer Patents Globe Newswire 9:00 AM

-- August 7, 2026 --

Femasys Secures $30 Million Private Placement, with Potential Proceeds of Up to $90 Million Globe Newswire 9:25 AM

-- June 24, 2026 --

Femasys Regains Compliance with Nasdaq Listing Requirements Globe Newswire 9:00 AM

-- May 13, 2026 --

Femasys Expands Fertility Care Portfolio in Europe with CE Mark Approval for FemHSG Catheter Globe Newswire 9:00 AM

-- May 8, 2026 --

Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update Globe Newswire 4:05 PM

-- May 5, 2026 --

Femasys Enables OB/GYNs to Deliver First-Line Fertility Treatment with Initial Commercial Use of FemaSeed Complete Globe Newswire 9:00 AM

-- April 22, 2026 --

Femasys Launches FemaSeed Complete for OB/GYNs at ACOG 2026 Globe Newswire 9:00 AM

-- April 16, 2026 --

Femasys Drives International Growth with Israeli Market Entry for Fertility Portfolio Globe Newswire 9:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software